In a total of 417 samples with IBMFS or associated hematological disorders, targeted proteomic analysis was found to provide a simple and direct diagnostic contribution for both patients with SDS and ADH5/ALDH2 deficiency. This evidence concerns the gene ADH5 and hematologic disorder.